Ultragenyx Pharmaceutical reported $782.75M in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Agios Pharmaceuticals USD 0 0 Mar/2025
Alnylam Pharmaceuticals USD 1.03B 956K Jun/2025
BioMarin Pharmaceutical USD 596.16M 512K Jun/2025
Insmed USD 560.95M 567.39M Jun/2025
Ionis Pharmaceuticals USD 625.49M 625.22M Jun/2025
Kyowa Hakko Kirin JPY 0 24.12B Mar/2025
MacroGenics USD 70.26M 70.26M Jun/2025
Moderna USD 32M 3M Jun/2025
Neurocrine Biosciences USD 0 0 Dec/2024
PTC Therapeutics USD 2.13B 1.85B Jun/2025
Regeneron Pharmaceuticals USD 1.99B 719.7M Jun/2025
Sarepta Therapeutics USD 1.14B 1.17M Jun/2025
Ultragenyx Pharmaceutical USD 782.75M 782.75M Jun/2025
Vertex Pharmaceuticals USD 112.8M 1.2M Dec/2024